Medesthetics

APR 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/958248

Contents of this Issue

Navigation

Page 11 of 68

• FDA cleared 1,2 • Non-invasive solution for fat destruction and IVK`JVU[V\YPUNPU[OLHIKVTLUÅHURZHUK thighs 1,2 • :LSLJ[P]LS`[HYNL[ZHUKIYLHRZKV^UMH[JLSSZ through focused ultrasound 3 • ;Y\S`JVTMVY[HISL^P[OHWHPUZJVYLVM#VUH WVPU[ZJHSL 4 • :[H[PZ[PJHSS`ZPNUPÄJHU[HIKVTPUHS circumference reduction of 2.4 cm to 2.6 cm HUKHTTMH[[OPJRULZZYLK\J[PVUVU average 1,5,a For more information about UltraShape Power, visit syneron-candela.com or contact your local Syneron Candela sales representative at 800-733-8550 . BEFORE AFTER Gentle, selective fat destruction UltraShape ® Power is a body-contouring system that delivers non-thermal, pulsed ultrasound waves to selectively destroy fat cells in a walk-in, walk-out procedure. Photos are unretouched and represent actual non–clinical study subject with signifi cant results. Individual results may vary. Photos courtesy of Suzanne Kilmer, MD. a In a clinical study at 12 weeks following the third treatment. 1. UltraShape Power 510(k) clearance for abdomen (K160896), July 2016. 2. UltraShape Power 510(k) clearance for fl anks and thighs (K170370), May 2017. 3. Brown SA, et al. Plast Reconstr Surg. 2009;124(1):92-101. 4. Amir R. Clinical Report, FDA, March 2016. Syneron Candela, data on fi le. 5. Multicenter study data. Syneron Candela, data on fi le. 6. Kilmer S. Before and after body photos. Syneron Candela, data on fi le. © 2018 Syneron Candela. This material contains registered trademarks, trade-names and brand names of Syneron Candela or its subsidiaries, including Syneron, Candela, and UltraShape. All other trademarks are the property of their respective owners. All rights reserved. PB89573EN-NA October 2017 Area treated: abdomen. In 3 treatments spaced 2 weeks apart, subject lost nearly 9 cm. Baseline: 89.5 cm. Post treatment: 80.7 cm. Weight loss: 3.1%. 6

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - APR 2018